Latest Breaking News On - Inhibikase therapeutics - Page 6 : comparemela.com

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

BOSTON and ATLANTA, Dec. 19, 2023 (GLOBE NEWSWIRE) Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage phar.

United statesAlex loboMiltonh wernerCompany contactInhibikase therapeutics incInhibikase or companyEuropean unionSternir incExchange commissionAbelson tyrosine kinasesFellow shareholdersInhibikase therapeuticsMultiple system atrophyOrphan drug designationAbelson tyrosine kinaseAbleson tyrosine

Inhibikase Therapeutics (IKT) Granted Pre-NDA Meeting with the FDA for IkT-001Pro

Inhibikase Therapeutics (IKT) Granted Pre-NDA Meeting with the FDA for IkT-001Pro
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMilton wernerDrug administrationInhibikase or companyInhibikase therapeutics incInhibikase therapeuticsAbelson tyrosine kinasesNew drug applicationChief executive officerAbelson tyrosine kinaseOrphan drug designation

12 Health Care Stocks Moving In Monday s After-Market Session - Amarin Corp (NASDAQ:AMRN), Acrivon Therapeutics (NASDAQ:ACRV)

Acrivon therapeuticsInhibikase therapeuticsAmarin corpTravere therapeuticsVirpax pharmaceuticals

Inhibikase Therapeutics (NYSE:IKT) versus Senti Biosciences (NASDAQ:SNTI) Head-To-Head Review

Inhibikase Therapeutics (NYSE:IKT – Get Free Report) and Senti Biosciences (NASDAQ:SNTI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. Institutional and Insider Ownership 14.0% of Inhibikase […]

United statesSouth san franciscoSphaera pharma pteInhibikase therapeutics incSenti biosciences incUniversity of bordeauxMichigan state universityArizona state universityJohns hopkins universityUniversity of californiaInhibikase therapeuticsGet free reportSenti biosciencesSenti bioscienceGiven inhibikase therapeuticSphaera pharma

DelveInsight Business Research, LLP: The Evolving Market Dynamics of Rare Diseases: WHIM Syndrome, Adrenal Crisis, Molybdenum Cofactor Deficiency Type-A (MoCoD-A), and Necrotizing Enterocolitis

DelveInsight Business Research, LLP: The Evolving Market Dynamics of Rare Diseases: WHIM Syndrome, Adrenal Crisis, Molybdenum Cofactor Deficiency Type-A (MoCoD-A), and Necrotizing Enterocolitis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAbbvie teneooneBristol myers squibbHeidelberg pharmaRoche genentechIndiens wirtschaftShruti thakurJohnson janssenTheravance biopharmaGensight biologicsIhre chancenHolostem terapie avanzateNoveome biotherapeuticsAmicus therapeuticsBrain neurotherapy bio incCorestem inc